VMD — Viemed Healthcare, Inc. stock price, charts and financials

QT75Viemed Healthcare, Inc.

Viemed Healthcare, Inc. (NASDAQ: VMD) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
9.84
-1.85-15.83%
VMDQT75Viemed Healthcare, Inc.·NASDAQ
9.84-15.83%
Earnings
Down 15.8% — Second quarter 2026 earnings miss (EPS down 33%) and material 8-K filing triggered sharp selloff.
High confidence
TA
Loading chart...
Screen all →
Snapshot
Index-P/E26.59EPS (ttm)0.37Insider Own13.40%Shs Outstand38.34MPerf Week-17.45%
Market Cap377.23MForward P/E16.13EPS next Y0.61Insider Trans-3.25%Shs Float33.10MPerf Month-18.88%
Enterprise Value378.23MPEG0.72EPS next Q-Inst Own-Short Float2.26%Perf Quarter3.80%
Income16.00MP/S1.32EPS this Y22.97%Inst Trans-Short Ratio2.65Perf Half Y23.00%
Sales286.00MP/B2.58EPS next Y34.07%ROA7.55%Short Interest747.08KPerf YTD32.44%
Book/sh3.81P/C37.73EPS next 5Y36.68%ROE10.66%52W High12.61 -21.97%Perf Year65.94%
Cash/sh0.26P/FCF17.41EPS past 3/5Y35.11% -14.71%ROIC10.53%52W Low5.96 65.10%Perf 3Y9.21%
Dividend Est.-EV/EBITDA7.14Sales past 3/5Y24.77% 15.56%Gross Margin57.32%Volatility4.60% 3.33%Perf 5Y46.21%
Dividend TTM-EV/Sales1.32EPS Y/Y TTM32.14%Oper. Margin8.38%ATR (14)0.51Perf 10Y-
Dividend Ex-Date-Quick Ratio1.10Sales Y/Y TTM27.68%Profit Margin5.20%RSI (14)25.93Recom2.00
Dividend Gr. 3/5Y-Current Ratio1.22EPS Q/Q0.00%SMA20-16.96%Beta1.07Target Price-
Payout0.00%Debt/Eq0.10Sales Q/Q27.12%SMA50-11.30%Rel Volume3.03Prev Close11.69
Employees1,382LT Debt/Eq0.09EarningsNov 04SMA20011.23%Avg Volume307.73KPrice9.84
IPO DateAug 09, 2019Option/ShortYes / YesEPS/Sales Surpr.-33.33% 1.36%Net Debt/EBITDA0.05Volume932,130Change-15.83%
Latest News
Company

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2862702241831391171318065
Cost of Goods Sold Incl. D&A12311591705444512417
Gross Profit1631551331138573805649
Selling, General and Administrative Excl. Other135130112947360584531
Research and Development433332110
Other Operating Expense120100-611
Operating Income2521181481227917
Interest Expense111000100
Unusual Expense
Non-Operating Income (Expense)12-101100-7
Net Income Before Taxes2222161491326910
Income Taxes765433-500
Consolidated Net Income161511106932910
Net Income From Continuing Operations161511106932910
Net Income161511106932910
EPS (Recurring)0.390.380.290.270.150.230.860.230.27
EPS (Basic, Before Extraordinaries)0.390.380.290.270.150.230.860.230.27
EPS (Diluted)0.370.370.280.250.150.220.820.220.26
EBITDA535242372524361614
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio26.5920.0828.6431.4050.4023.739.4628.1814.62
Price To Sales Ratio1.311.071.401.632.121.742.312.952.22
Gross Margin56.9957.4159.3861.7561.1562.3961.0770.0075.38
Operating Margin8.747.788.047.655.7610.2620.6111.2526.15
Net Margin5.595.564.915.464.327.6924.4311.2515.38
Shares Outstanding383939383939393838
Market Capitalization374290313298295204303236144
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$13.29$11.21$9.13$7.05$4.97 Close Price0.00M0.31M0.62M0.93M1.24MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Frazier WilliamChief Medical OfficerJun 25 '26Option Exercise1.8110,00018,10083,214Jun 26
Frazier WilliamChief Medical OfficerJun 25 '26Sale11.7210,000117,20073,214Jun 26
Smokoff TimothyDirectorJun 24 '26Sale11.5020,000229,96775,518Jun 26
Moore MichaelPresidentMar 20 '26Sale8.7765,000570,0501,585,812Mar 20
Moore MichaelPresidentMar 19 '26Sale9.2140,232370,5371,650,812Mar 20
Moore MichaelPresidentMar 18 '26Sale9.4231,570297,3891,691,044Mar 20
Trahan JeremyGeneral CounselJan 29 '26Option Exercise0.0014,365050,083Feb 02
Frazier WilliamChief Medical OfficerJan 29 '26Option Exercise0.003,112074,016Feb 02
Fitzgerald TraeChief Financial OfficerJan 29 '26Option Exercise0.0013,0590108,903Feb 02
ZEHNDER WILLIAM TODDChief Operating OfficerJan 29 '26Option Exercise0.0035,7900401,677Feb 02
Hoyt CaseyChief Executive OfficerJan 29 '26Option Exercise0.0053,0600364,377Feb 02
Cambre JeromeVice President of SalesJan 29 '26Option Exercise0.0011,4920106,961Feb 02
Moore MichaelPresidentJan 29 '26Option Exercise0.0035,7890198,037Feb 02
Cambre JeromeVice President of SalesJan 21 '26Option Exercise0.0014,6490101,651Jan 23
Frazier WilliamChief Medical OfficerJan 21 '26Option Exercise0.004,251072,851Jan 23
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.